Pramipexole to Improve Cognition in Bipolar Disorder: A Randomized Controlled Trial

BACKGROUND: Adults with bipolar disorder (BD) often experience neurocognitive impairment that negatively impacts functioning and quality of life. Previous trials have found that dopamine agonist agents improve cognition in healthy volunteers and that adults with BD who have stable mood and mild cogn...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Meter, Anna R., Perez-Rodriguez, M. Mercedes, Braga, Raphael J., Shanahan, Megan, Hanna, Lauren, Malhotra, Anil K., Burdick, Katherine E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238822/
https://www.ncbi.nlm.nih.gov/pubmed/33956703
http://dx.doi.org/10.1097/JCP.0000000000001407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238822/
https://www.ncbi.nlm.nih.gov/pubmed/33956703
http://dx.doi.org/10.1097/JCP.0000000000001407

Ejemplares similares